Our products are branded generic and licensed drugs for the treatment of serious and debilitating diseases of sub-Saharan Africa. These include:

·        Antiretrovirals and combinations for treating HIV AIDS

·        Broad spectrum antibacterials against beta-lactam resistant bacterial infections

·        Drugs for the treatment of opportunistic infections in immunocompromised patients, including AIDS patients

·        Topical antiinfectives against various skin and soft tissue infections

·        Antimalarial regimens for combating chloroquine resistant falciparum malaria